Rank | Gene Set | Z-score |
---|---|---|
1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.11084218 |
2 | chaperone-mediated protein transport (GO:0072321) | 7.13567307 |
3 | maintenance of protein location in nucleus (GO:0051457) | 6.92594675 |
4 | somite rostral/caudal axis specification (GO:0032525) | 6.68669720 |
5 | negative regulation of epidermis development (GO:0045683) | 6.48214489 |
6 | regulation of response to osmotic stress (GO:0047484) | 6.47935537 |
7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.25843401 |
8 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.06038428 |
9 | protein localization to kinetochore (GO:0034501) | 5.92704751 |
10 | negative regulation of telomerase activity (GO:0051974) | 5.79712588 |
11 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.74217147 |
12 | muscle organ morphogenesis (GO:0048644) | 5.61061679 |
13 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.58263600 |
14 | cytidine deamination (GO:0009972) | 5.52988350 |
15 | cytidine metabolic process (GO:0046087) | 5.52988350 |
16 | cytidine catabolic process (GO:0006216) | 5.52988350 |
17 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.48311750 |
18 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.39538558 |
19 | rRNA transcription (GO:0009303) | 5.38258646 |
20 | histone H4-K8 acetylation (GO:0043982) | 5.36403611 |
21 | histone H4-K5 acetylation (GO:0043981) | 5.36403611 |
22 | regulation of cilium movement (GO:0003352) | 5.31982809 |
23 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.26052057 |
24 | ATP synthesis coupled proton transport (GO:0015986) | 5.19152109 |
25 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.19152109 |
26 | negative regulation of epidermal cell differentiation (GO:0045605) | 5.15798890 |
27 | quinone metabolic process (GO:1901661) | 5.12058481 |
28 | rRNA methylation (GO:0031167) | 5.11193751 |
29 | notochord development (GO:0030903) | 5.09668927 |
30 | response to dietary excess (GO:0002021) | 5.05943349 |
31 | histone H4-K12 acetylation (GO:0043983) | 4.97533944 |
32 | phenol-containing compound catabolic process (GO:0019336) | 4.97210966 |
33 | hormone catabolic process (GO:0042447) | 4.92452140 |
34 | coenzyme catabolic process (GO:0009109) | 4.90067935 |
35 | rRNA modification (GO:0000154) | 4.80073137 |
36 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 4.71881567 |
37 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.70955038 |
38 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 4.67920640 |
39 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.66530015 |
40 | DNA deamination (GO:0045006) | 4.60353825 |
41 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.58615302 |
42 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.58615302 |
43 | mitotic sister chromatid segregation (GO:0000070) | 4.55854693 |
44 | protein complex biogenesis (GO:0070271) | 4.47017666 |
45 | primitive streak formation (GO:0090009) | 4.30654154 |
46 | cullin deneddylation (GO:0010388) | 4.29355983 |
47 | protein localization to chromosome, centromeric region (GO:0071459) | 4.28659923 |
48 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.23133439 |
49 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.22019251 |
50 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.22019251 |
51 | regulation of translation in response to stress (GO:0043555) | 4.19488783 |
52 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.18860477 |
53 | negative regulation of telomere maintenance (GO:0032205) | 4.18831664 |
54 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.16293612 |
55 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.15319790 |
56 | heterochromatin organization (GO:0070828) | 4.14722582 |
57 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.13535048 |
58 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.13535048 |
59 | NADH dehydrogenase complex assembly (GO:0010257) | 4.13535048 |
60 | respiratory chain complex IV assembly (GO:0008535) | 4.12861010 |
61 | cellular modified amino acid catabolic process (GO:0042219) | 4.10295112 |
62 | cytochrome complex assembly (GO:0017004) | 4.05436940 |
63 | histone H4-K16 acetylation (GO:0043984) | 4.02911033 |
64 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.02641407 |
65 | DNA replication checkpoint (GO:0000076) | 4.00278312 |
66 | interferon-gamma production (GO:0032609) | 3.99734885 |
67 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.98467968 |
68 | protein neddylation (GO:0045116) | 3.94958696 |
69 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.93954732 |
70 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.93423544 |
71 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.88200505 |
72 | protein deneddylation (GO:0000338) | 3.85555211 |
73 | pseudouridine synthesis (GO:0001522) | 3.85079759 |
74 | respiratory electron transport chain (GO:0022904) | 3.81270696 |
75 | cardiovascular system development (GO:0072358) | 3.78365589 |
76 | electron transport chain (GO:0022900) | 3.78095450 |
77 | DNA damage response, detection of DNA damage (GO:0042769) | 3.76145718 |
78 | epoxygenase P450 pathway (GO:0019373) | 3.74845935 |
79 | regulation of telomerase activity (GO:0051972) | 3.68620640 |
80 | mitochondrion distribution (GO:0048311) | 3.68317055 |
81 | microtubule severing (GO:0051013) | 3.67287903 |
82 | chromatin assembly (GO:0031497) | 3.67154688 |
83 | biotin metabolic process (GO:0006768) | 3.66729448 |
84 | intestinal epithelial cell development (GO:0060576) | 3.66082757 |
85 | transepithelial transport (GO:0070633) | 3.63296367 |
86 | transcription from mitochondrial promoter (GO:0006390) | 3.61909770 |
87 | GDP-mannose metabolic process (GO:0019673) | 3.58913790 |
88 | proline transport (GO:0015824) | 3.58154072 |
89 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.57497679 |
90 | termination of RNA polymerase III transcription (GO:0006386) | 3.57497679 |
91 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.57389171 |
92 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.53441039 |
93 | response to pheromone (GO:0019236) | 3.52584648 |
94 | sister chromatid segregation (GO:0000819) | 3.52561654 |
95 | maintenance of protein localization in organelle (GO:0072595) | 3.51907692 |
96 | icosanoid secretion (GO:0032309) | 3.51239056 |
97 | arachidonic acid secretion (GO:0050482) | 3.51239056 |
98 | ribosome biogenesis (GO:0042254) | 3.41928248 |
99 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.36543532 |
100 | omega-hydroxylase P450 pathway (GO:0097267) | 3.35679222 |
101 | intracellular protein transmembrane import (GO:0044743) | 3.34023565 |
102 | retinoic acid receptor signaling pathway (GO:0048384) | 3.30660285 |
103 | positive regulation of protein deacetylation (GO:0090312) | 3.28077896 |
104 | protein polyglutamylation (GO:0018095) | 3.25121971 |
105 | detection of temperature stimulus (GO:0016048) | 3.24274083 |
106 | negative regulation of interleukin-2 production (GO:0032703) | 3.23111887 |
107 | proteasome assembly (GO:0043248) | 3.22316403 |
108 | regulation of microtubule-based movement (GO:0060632) | 3.21757083 |
109 | regulation of telomere maintenance (GO:0032204) | 3.18070072 |
110 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.13956294 |
111 | cell wall macromolecule catabolic process (GO:0016998) | 3.13467662 |
112 | protein-cofactor linkage (GO:0018065) | 3.12657419 |
113 | positive regulation of digestive system process (GO:0060456) | 3.12656850 |
114 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.10775372 |
115 | viral transcription (GO:0019083) | 3.10093841 |
116 | trophectodermal cell differentiation (GO:0001829) | 3.08882820 |
117 | translational termination (GO:0006415) | 3.08594717 |
118 | behavioral response to nicotine (GO:0035095) | 3.07469667 |
119 | nuclear pore complex assembly (GO:0051292) | 3.07059794 |
120 | primary alcohol catabolic process (GO:0034310) | 3.04773912 |
121 | ribosomal small subunit assembly (GO:0000028) | 3.01363355 |
122 | positive regulation of gluconeogenesis (GO:0045722) | 3.00916279 |
123 | cotranslational protein targeting to membrane (GO:0006613) | 3.00020501 |
124 | ribosomal small subunit biogenesis (GO:0042274) | 2.99698651 |
125 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.98960772 |
126 | bone trabecula formation (GO:0060346) | 2.98439399 |
127 | translational elongation (GO:0006414) | 2.98398859 |
128 | apoptotic DNA fragmentation (GO:0006309) | 2.96076351 |
129 | formation of translation preinitiation complex (GO:0001731) | 2.95670053 |
130 | platelet dense granule organization (GO:0060155) | 2.94122085 |
131 | mitochondrial DNA replication (GO:0006264) | 2.94073112 |
132 | ATP biosynthetic process (GO:0006754) | 2.93491425 |
133 | cellular component biogenesis (GO:0044085) | 2.93204069 |
134 | vitamin A metabolic process (GO:0006776) | 2.93197367 |
135 | protein targeting to ER (GO:0045047) | 2.92347632 |
136 | translation (GO:0006412) | 2.92000189 |
137 | regulation of gene silencing by RNA (GO:0060966) | 2.91947565 |
138 | regulation of gene silencing by miRNA (GO:0060964) | 2.91947565 |
139 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.88377413 |
140 | hydrogen ion transmembrane transport (GO:1902600) | 2.86691262 |
141 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.82881329 |
142 | tRNA processing (GO:0008033) | 2.80750670 |
143 | chromatin remodeling at centromere (GO:0031055) | 2.80600971 |
144 | protein localization to endoplasmic reticulum (GO:0070972) | 2.79623099 |
145 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.79601242 |
146 | aerobic respiration (GO:0009060) | 2.76956065 |
147 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.76825063 |
148 | peptidyl-histidine modification (GO:0018202) | 2.76817071 |
149 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.76365357 |
150 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.76365357 |
151 | histone H2A acetylation (GO:0043968) | 2.75270993 |
152 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.74619765 |
153 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.73795787 |
154 | maturation of 5.8S rRNA (GO:0000460) | 2.72520474 |
155 | proton transport (GO:0015992) | 2.70875314 |
156 | mitochondrion morphogenesis (GO:0070584) | 2.70386364 |
157 | cell wall macromolecule metabolic process (GO:0044036) | 2.70218954 |
158 | protein targeting to mitochondrion (GO:0006626) | 2.69067175 |
159 | hydrogen transport (GO:0006818) | 2.67770851 |
160 | peroxisome fission (GO:0016559) | 2.66511982 |
161 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.66398260 |
162 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.66153926 |
163 | piRNA metabolic process (GO:0034587) | 2.65283219 |
164 | CENP-A containing nucleosome assembly (GO:0034080) | 2.65026605 |
165 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.62406717 |
166 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.62406717 |
167 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.62252509 |
168 | replication fork processing (GO:0031297) | 2.61762656 |
169 | ribosomal large subunit biogenesis (GO:0042273) | 2.61058468 |
170 | establishment of protein localization to mitochondrion (GO:0072655) | 2.61003822 |
171 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.59323918 |
172 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.59323918 |
173 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.59323918 |
174 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.59105943 |
175 | otic vesicle formation (GO:0030916) | 2.56494558 |
176 | rRNA processing (GO:0006364) | 2.55561655 |
177 | L-fucose catabolic process (GO:0042355) | 2.55088441 |
178 | fucose catabolic process (GO:0019317) | 2.55088441 |
179 | L-fucose metabolic process (GO:0042354) | 2.55088441 |
180 | mannosylation (GO:0097502) | 2.54887616 |
181 | rRNA metabolic process (GO:0016072) | 2.54190035 |
182 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.54136920 |
183 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.54136920 |
184 | negative regulation of membrane potential (GO:0045837) | 2.53836828 |
185 | pantothenate metabolic process (GO:0015939) | 2.52319994 |
186 | amino acid salvage (GO:0043102) | 2.50433524 |
187 | L-methionine salvage (GO:0071267) | 2.50433524 |
188 | L-methionine biosynthetic process (GO:0071265) | 2.50433524 |
189 | serine family amino acid catabolic process (GO:0009071) | 2.48632688 |
190 | daunorubicin metabolic process (GO:0044597) | 12.3479773 |
191 | polyketide metabolic process (GO:0030638) | 12.3479773 |
192 | doxorubicin metabolic process (GO:0044598) | 12.3479773 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.90973975 |
2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.90973975 |
3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.90973975 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.64527380 |
5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.55803230 |
6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.33573562 |
7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.16853830 |
8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.40821364 |
9 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.38457034 |
10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.24279158 |
11 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.93816682 |
12 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.93755210 |
13 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.92723377 |
14 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.79669380 |
15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.59561497 |
16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.53709803 |
17 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.50009255 |
18 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.49989720 |
19 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.49831075 |
20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.42679010 |
21 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.41415824 |
22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.40414339 |
23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.40111699 |
24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.37953923 |
25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.34749757 |
26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.22341671 |
27 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.20902831 |
28 | FUS_26573619_Chip-Seq_HEK293_Human | 2.18852671 |
29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.11680659 |
30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.08114768 |
31 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.02590499 |
32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.00429179 |
33 | EWS_26573619_Chip-Seq_HEK293_Human | 1.97986140 |
34 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.97979988 |
35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.94048741 |
36 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.94039028 |
37 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.93380477 |
38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.92864551 |
39 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.85845909 |
40 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.80289178 |
41 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.79407197 |
42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.76837294 |
43 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.73633781 |
44 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.72391811 |
45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72248431 |
46 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.72207858 |
47 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.70560419 |
48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.68762331 |
49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.67316211 |
50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.66408145 |
51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65818676 |
52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.65277264 |
53 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.62965284 |
54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61388093 |
55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.57300830 |
56 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.56721164 |
57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.54402539 |
58 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54101487 |
59 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.53799001 |
60 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.52704047 |
61 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.50194195 |
62 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.49209316 |
63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47216545 |
64 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.46259034 |
65 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44905988 |
66 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.44245615 |
67 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.44194124 |
68 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.43062123 |
69 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.42587385 |
70 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.41713820 |
71 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.41633268 |
72 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41029328 |
73 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.39608893 |
74 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.38560854 |
75 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.37968342 |
76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36802830 |
77 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.33977647 |
78 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.32921912 |
79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31921764 |
80 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29114032 |
81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.28808080 |
82 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.28225601 |
83 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.27755839 |
84 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.27505712 |
85 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27174591 |
86 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26415726 |
87 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26271904 |
88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24474701 |
89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23597724 |
90 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.23269999 |
91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.20391344 |
92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19885358 |
93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19885358 |
94 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.19523329 |
95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18974907 |
96 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.18830396 |
97 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.16522361 |
98 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.12655978 |
99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12530646 |
100 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11544518 |
101 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11454018 |
102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11291147 |
103 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.10486674 |
104 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08736207 |
105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08736207 |
106 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08644180 |
107 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.07839351 |
108 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07732078 |
109 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07250512 |
110 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.05234973 |
111 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.05212454 |
112 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05197830 |
113 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.04538809 |
114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03465458 |
115 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02968526 |
116 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02589722 |
117 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02589722 |
118 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01745726 |
119 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.00890957 |
120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99848717 |
121 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.98919851 |
122 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98217675 |
123 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97952757 |
124 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97267540 |
125 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.96162576 |
126 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96009802 |
127 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94776659 |
128 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94707031 |
129 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.94351347 |
130 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.93293963 |
131 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92995316 |
132 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92873304 |
133 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.92281781 |
134 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92027786 |
135 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91228032 |
136 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91177642 |
137 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90811270 |
138 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.90689840 |
139 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.90550461 |
140 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.89807197 |
141 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.89585234 |
142 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.89408891 |
143 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89161418 |
144 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88675743 |
145 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88672535 |
146 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88306259 |
147 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.87369190 |
148 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.86626391 |
149 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.86367540 |
150 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.80478561 |
151 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79842320 |
152 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.77944251 |
153 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.77157619 |
154 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.77018604 |
155 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.76614607 |
156 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.76189104 |
157 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.75222717 |
158 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.75146996 |
159 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.74082358 |
160 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.73673848 |
161 | * STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.73642959 |
162 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.73059312 |
163 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.72503764 |
164 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.71057221 |
165 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.70805605 |
166 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.69937934 |
167 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.69393080 |
168 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.68278195 |
169 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.68096714 |
170 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.67370538 |
171 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.67039058 |
172 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.66579202 |
173 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.66127219 |
174 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.65986592 |
175 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.64372107 |
176 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.64031995 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003011_delayed_dark_adaptation | 5.37408392 |
2 | MP0002254_reproductive_system_inflammat | 4.60666638 |
3 | MP0006292_abnormal_olfactory_placode | 4.44760423 |
4 | MP0004264_abnormal_extraembryonic_tissu | 4.05854176 |
5 | MP0005499_abnormal_olfactory_system | 3.66449291 |
6 | MP0005394_taste/olfaction_phenotype | 3.66449291 |
7 | MP0005075_abnormal_melanosome_morpholog | 3.40230272 |
8 | MP0002638_abnormal_pupillary_reflex | 3.31087335 |
9 | MP0003890_abnormal_embryonic-extraembry | 3.29421230 |
10 | MP0004858_abnormal_nervous_system | 3.17655712 |
11 | MP0002332_abnormal_exercise_endurance | 3.12124334 |
12 | MP0006072_abnormal_retinal_apoptosis | 3.06240681 |
13 | MP0003646_muscle_fatigue | 2.93269809 |
14 | MP0006035_abnormal_mitochondrial_morpho | 2.83384035 |
15 | MP0008877_abnormal_DNA_methylation | 2.76936211 |
16 | MP0003122_maternal_imprinting | 2.73664799 |
17 | MP0004957_abnormal_blastocyst_morpholog | 2.73020733 |
18 | MP0002102_abnormal_ear_morphology | 2.65996235 |
19 | MP0008057_abnormal_DNA_replication | 2.50508096 |
20 | MP0002837_dystrophic_cardiac_calcinosis | 2.43517064 |
21 | MP0000372_irregular_coat_pigmentation | 2.35372566 |
22 | MP0008058_abnormal_DNA_repair | 2.20905739 |
23 | MP0005257_abnormal_intraocular_pressure | 2.18274121 |
24 | MP0003718_maternal_effect | 2.17007409 |
25 | MP0002938_white_spotting | 2.15055628 |
26 | MP0003195_calcinosis | 2.04466308 |
27 | MP0002127_abnormal_cardiovascular_syste | 2.02902212 |
28 | MP0000678_abnormal_parathyroid_gland | 2.02445714 |
29 | MP0005551_abnormal_eye_electrophysiolog | 1.99778758 |
30 | MP0003121_genomic_imprinting | 1.98298393 |
31 | MP0003938_abnormal_ear_development | 1.97709106 |
32 | MP0003787_abnormal_imprinting | 1.93389942 |
33 | MP0002277_abnormal_respiratory_mucosa | 1.89394673 |
34 | MP0001529_abnormal_vocalization | 1.85843131 |
35 | MP0003705_abnormal_hypodermis_morpholog | 1.84722491 |
36 | MP0001986_abnormal_taste_sensitivity | 1.83505711 |
37 | MP0002653_abnormal_ependyma_morphology | 1.81572550 |
38 | MP0009379_abnormal_foot_pigmentation | 1.72892974 |
39 | MP0004142_abnormal_muscle_tone | 1.71866104 |
40 | MP0004043_abnormal_pH_regulation | 1.71574048 |
41 | MP0008961_abnormal_basal_metabolism | 1.71387652 |
42 | MP0000762_abnormal_tongue_morphology | 1.71128589 |
43 | MP0003186_abnormal_redox_activity | 1.68463163 |
44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.68143694 |
45 | MP0005084_abnormal_gallbladder_morpholo | 1.67179078 |
46 | MP0005646_abnormal_pituitary_gland | 1.62296457 |
47 | MP0003137_abnormal_impulse_conducting | 1.61673296 |
48 | * MP0001672_abnormal_embryogenesis/_devel | 1.59234091 |
49 | * MP0005380_embryogenesis_phenotype | 1.59234091 |
50 | MP0010352_gastrointestinal_tract_polyps | 1.58435860 |
51 | MP0001968_abnormal_touch/_nociception | 1.56667343 |
52 | MP0008789_abnormal_olfactory_epithelium | 1.53838765 |
53 | MP0003183_abnormal_peptide_metabolism | 1.51721900 |
54 | MP0004381_abnormal_hair_follicle | 1.51608193 |
55 | MP0001984_abnormal_olfaction | 1.51477488 |
56 | MP0000049_abnormal_middle_ear | 1.47725437 |
57 | MP0001485_abnormal_pinna_reflex | 1.46628117 |
58 | MP0000750_abnormal_muscle_regeneration | 1.46168696 |
59 | MP0000749_muscle_degeneration | 1.45950162 |
60 | MP0003880_abnormal_central_pattern | 1.44918057 |
61 | MP0002160_abnormal_reproductive_system | 1.44627758 |
62 | * MP0002088_abnormal_embryonic_growth/wei | 1.43566935 |
63 | MP0005266_abnormal_metabolism | 1.42738233 |
64 | * MP0003984_embryonic_growth_retardation | 1.42426574 |
65 | MP0002736_abnormal_nociception_after | 1.41405561 |
66 | MP0010030_abnormal_orbit_morphology | 1.39802419 |
67 | MP0005379_endocrine/exocrine_gland_phen | 1.38914570 |
68 | MP0002163_abnormal_gland_morphology | 1.38701531 |
69 | MP0003123_paternal_imprinting | 1.38659984 |
70 | MP0003693_abnormal_embryo_hatching | 1.37967640 |
71 | MP0001764_abnormal_homeostasis | 1.30302508 |
72 | MP0002932_abnormal_joint_morphology | 1.29769344 |
73 | MP0002876_abnormal_thyroid_physiology | 1.29516968 |
74 | MP0002272_abnormal_nervous_system | 1.29095166 |
75 | MP0005389_reproductive_system_phenotype | 1.28770011 |
76 | MP0006036_abnormal_mitochondrial_physio | 1.28234089 |
77 | MP0004147_increased_porphyrin_level | 1.27558408 |
78 | MP0009745_abnormal_behavioral_response | 1.27464626 |
79 | MP0002269_muscular_atrophy | 1.25447096 |
80 | MP0009046_muscle_twitch | 1.25401637 |
81 | MP0002233_abnormal_nose_morphology | 1.25166910 |
82 | MP0008995_early_reproductive_senescence | 1.21758121 |
83 | MP0004145_abnormal_muscle_electrophysio | 1.19902326 |
84 | MP0005174_abnormal_tail_pigmentation | 1.19394881 |
85 | MP0001293_anophthalmia | 1.18041016 |
86 | MP0003567_abnormal_fetal_cardiomyocyte | 1.16931440 |
87 | MP0002092_abnormal_eye_morphology | 1.13232852 |
88 | MP0000631_abnormal_neuroendocrine_gland | 1.12320774 |
89 | MP0000350_abnormal_cell_proliferation | 1.11042189 |
90 | MP0001905_abnormal_dopamine_level | 1.10366519 |
91 | MP0002970_abnormal_white_adipose | 1.07329191 |
92 | MP0005195_abnormal_posterior_eye | 1.07328028 |
93 | MP0001849_ear_inflammation | 1.06749739 |
94 | MP0005645_abnormal_hypothalamus_physiol | 1.06506470 |
95 | MP0001501_abnormal_sleep_pattern | 1.06056965 |
96 | MP0002114_abnormal_axial_skeleton | 1.05408777 |
97 | MP0002085_abnormal_embryonic_tissue | 1.05302740 |
98 | MP0002095_abnormal_skin_pigmentation | 1.03838832 |
99 | MP0003315_abnormal_perineum_morphology | 1.03397361 |
100 | MP0003077_abnormal_cell_cycle | 1.02979912 |
101 | MP0002210_abnormal_sex_determination | 1.02076939 |
102 | MP0002086_abnormal_extraembryonic_tissu | 1.01721593 |
103 | MP0006082_CNS_inflammation | 0.98667915 |
104 | MP0003136_yellow_coat_color | 0.96466338 |
105 | MP0005330_cardiomyopathy | 0.96023104 |
106 | MP0001348_abnormal_lacrimal_gland | 0.95915280 |
107 | MP0001929_abnormal_gametogenesis | 0.94718532 |
108 | MP0001919_abnormal_reproductive_system | 0.94473330 |
109 | MP0002396_abnormal_hematopoietic_system | 0.93723361 |
110 | MP0003755_abnormal_palate_morphology | 0.93622052 |
111 | MP0003950_abnormal_plasma_membrane | 0.92430032 |
112 | MP0000428_abnormal_craniofacial_morphol | 0.92378943 |
113 | MP0002249_abnormal_larynx_morphology | 0.92045342 |
114 | MP0006276_abnormal_autonomic_nervous | 0.91928322 |
115 | MP0005332_abnormal_amino_acid | 0.91473339 |
116 | MP0002234_abnormal_pharynx_morphology | 0.91341631 |
117 | MP0004885_abnormal_endolymph | 0.91141136 |
118 | MP0001324_abnormal_eye_pigmentation | 0.88840377 |
119 | MP0004742_abnormal_vestibular_system | 0.87505536 |
120 | MP0000653_abnormal_sex_gland | 0.87084479 |
121 | MP0001486_abnormal_startle_reflex | 0.86470689 |
122 | MP0003119_abnormal_digestive_system | 0.86419128 |
123 | MP0005377_hearing/vestibular/ear_phenot | 0.86187586 |
124 | MP0003878_abnormal_ear_physiology | 0.86187586 |
125 | MP0001145_abnormal_male_reproductive | 0.85307196 |
126 | MP0004215_abnormal_myocardial_fiber | 0.84769681 |
127 | MP0004133_heterotaxia | 0.84648706 |
128 | MP0002098_abnormal_vibrissa_morphology | 0.84643957 |
129 | MP0002084_abnormal_developmental_patter | 0.84104324 |
130 | MP0003111_abnormal_nucleus_morphology | 0.83953774 |
131 | MP0000432_abnormal_head_morphology | 0.83449820 |
132 | MP0005410_abnormal_fertilization | 0.83333326 |
133 | MP0002572_abnormal_emotion/affect_behav | 0.83249446 |
134 | MP0000647_abnormal_sebaceous_gland | 0.83014751 |
135 | MP0005423_abnormal_somatic_nervous | 0.82735838 |
136 | MP0008770_decreased_survivor_rate | 0.82448964 |
137 | MP0002557_abnormal_social/conspecific_i | 0.81628987 |
138 | MP0005391_vision/eye_phenotype | 0.81049960 |
139 | MP0003698_abnormal_male_reproductive | 0.80233570 |
140 | MP0002132_abnormal_respiratory_system | 0.80041591 |
141 | MP0000759_abnormal_skeletal_muscle | 0.79871945 |
142 | MP0002796_impaired_skin_barrier | 0.79118658 |
143 | MP0002752_abnormal_somatic_nervous | 0.78669441 |
144 | MP0010094_abnormal_chromosome_stability | 0.78040363 |
145 | MP0003935_abnormal_craniofacial_develop | 0.77181168 |
146 | MP0005671_abnormal_response_to | 0.76746119 |
147 | MP0001119_abnormal_female_reproductive | 0.76126130 |
148 | MP0009764_decreased_sensitivity_to | 0.73118054 |
149 | MP0001730_embryonic_growth_arrest | 0.72472847 |
150 | MP0002734_abnormal_mechanical_nocicepti | 0.71894009 |
151 | MP0008932_abnormal_embryonic_tissue | 0.71480019 |
152 | MP0005508_abnormal_skeleton_morphology | 0.70241917 |
153 | MP0002751_abnormal_autonomic_nervous | 0.69945230 |
154 | MP0005248_abnormal_Harderian_gland | 0.68861200 |
155 | MP0004085_abnormal_heartbeat | 0.67938061 |
156 | MP0009115_abnormal_fat_cell | 0.66108200 |
157 | MP0000313_abnormal_cell_death | 0.65616484 |
158 | MP0004084_abnormal_cardiac_muscle | 0.64850586 |
159 | MP0000358_abnormal_cell_content/ | 0.64372077 |
160 | MP0001697_abnormal_embryo_size | 0.63398899 |
161 | MP0003786_premature_aging | 0.63169697 |
162 | MP0003937_abnormal_limbs/digits/tail_de | 0.61824599 |
163 | MP0008872_abnormal_physiological_respon | 0.61535502 |
164 | MP0005253_abnormal_eye_physiology | 0.61118998 |
165 | MP0004087_abnormal_muscle_fiber | 0.60755556 |
166 | MP0002925_abnormal_cardiovascular_devel | 0.60547780 |
167 | MP0004197_abnormal_fetal_growth/weight/ | 0.58274490 |
168 | MP0002116_abnormal_craniofacial_bone | 0.58015905 |
169 | MP0010630_abnormal_cardiac_muscle | 0.57862429 |
170 | * MP0002080_prenatal_lethality | 0.57261191 |
171 | MP0000383_abnormal_hair_follicle | 0.57205719 |
172 | MP0000490_abnormal_crypts_of | 0.57205682 |
173 | MP0003806_abnormal_nucleotide_metabolis | 0.56956389 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Bilateral microphthalmos (HP:0007633) | 7.52274810 |
2 | Hypochromic microcytic anemia (HP:0004840) | 5.69547257 |
3 | Multiple enchondromatosis (HP:0005701) | 5.64385359 |
4 | Hepatoblastoma (HP:0002884) | 5.10197600 |
5 | Rib fusion (HP:0000902) | 4.66110163 |
6 | Testicular atrophy (HP:0000029) | 4.48995732 |
7 | Abnormality of the lower motor neuron (HP:0002366) | 4.42119901 |
8 | Mitochondrial inheritance (HP:0001427) | 3.99237644 |
9 | Increased hepatocellular lipid droplets (HP:0006565) | 3.97687283 |
10 | Ependymoma (HP:0002888) | 3.95704585 |
11 | Lipid accumulation in hepatocytes (HP:0006561) | 3.88377933 |
12 | Acute necrotizing encephalopathy (HP:0006965) | 3.86520899 |
13 | Increased CSF lactate (HP:0002490) | 3.86441185 |
14 | Ragged-red muscle fibers (HP:0003200) | 3.84757433 |
15 | Methylmalonic acidemia (HP:0002912) | 3.82721319 |
16 | Neoplasm of striated muscle (HP:0009728) | 3.75623040 |
17 | Hepatocellular necrosis (HP:0001404) | 3.74454943 |
18 | Partial duplication of thumb phalanx (HP:0009944) | 3.70501456 |
19 | Hepatic necrosis (HP:0002605) | 3.56067871 |
20 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.52835033 |
21 | Rhabdomyosarcoma (HP:0002859) | 3.50863544 |
22 | Hypoplasia of the fovea (HP:0007750) | 3.47133792 |
23 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.47133792 |
24 | Bifid tongue (HP:0010297) | 3.44719600 |
25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.42494224 |
26 | Hyperglycinemia (HP:0002154) | 3.42340685 |
27 | Acute encephalopathy (HP:0006846) | 3.37788854 |
28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.34979611 |
29 | Rectovaginal fistula (HP:0000143) | 3.34948240 |
30 | Rectal fistula (HP:0100590) | 3.34948240 |
31 | Progressive macrocephaly (HP:0004481) | 3.34209653 |
32 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.30357673 |
33 | Anomalous pulmonary venous return (HP:0010772) | 3.25870198 |
34 | Embryonal renal neoplasm (HP:0011794) | 3.24366892 |
35 | Renal Fanconi syndrome (HP:0001994) | 3.23643806 |
36 | Pancreatic fibrosis (HP:0100732) | 3.22609190 |
37 | Pancreatic cysts (HP:0001737) | 3.20479943 |
38 | Abnormality of the salivary glands (HP:0010286) | 3.20467011 |
39 | Partial duplication of the phalanx of hand (HP:0009999) | 3.18139742 |
40 | Methylmalonic aciduria (HP:0012120) | 3.15084186 |
41 | Progressive muscle weakness (HP:0003323) | 3.10702148 |
42 | Abnormality of midbrain morphology (HP:0002418) | 3.09819159 |
43 | Molar tooth sign on MRI (HP:0002419) | 3.09819159 |
44 | Abnormal lung lobation (HP:0002101) | 3.02146138 |
45 | True hermaphroditism (HP:0010459) | 2.98612329 |
46 | Hypoplasia of the pons (HP:0012110) | 2.94360368 |
47 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.93519246 |
48 | Trismus (HP:0000211) | 2.93385369 |
49 | Vaginal fistula (HP:0004320) | 2.92433701 |
50 | Fused cervical vertebrae (HP:0002949) | 2.91991854 |
51 | Intestinal fistula (HP:0100819) | 2.90643646 |
52 | Hyperventilation (HP:0002883) | 2.88101517 |
53 | Global brain atrophy (HP:0002283) | 2.86525786 |
54 | Abnormal cartilage morphology (HP:0002763) | 2.86047361 |
55 | Difficulty running (HP:0009046) | 2.85797062 |
56 | Chromsome breakage (HP:0040012) | 2.84201036 |
57 | Abnormal number of erythroid precursors (HP:0012131) | 2.82423184 |
58 | Abnormality of the pons (HP:0007361) | 2.79836721 |
59 | Periauricular skin pits (HP:0100277) | 2.78706393 |
60 | Preauricular pit (HP:0004467) | 2.78706393 |
61 | Increased serum lactate (HP:0002151) | 2.74432596 |
62 | Abnormality of the pulmonary veins (HP:0011718) | 2.74066827 |
63 | 3-Methylglutaconic aciduria (HP:0003535) | 2.73963135 |
64 | Amyotrophic lateral sclerosis (HP:0007354) | 2.73687711 |
65 | Horizontal nystagmus (HP:0000666) | 2.73576795 |
66 | Tetraplegia (HP:0002445) | 2.71315324 |
67 | Abnormality of alanine metabolism (HP:0010916) | 2.68594051 |
68 | Hyperalaninemia (HP:0003348) | 2.68594051 |
69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.68594051 |
70 | Abnormality of the astrocytes (HP:0100707) | 2.65643508 |
71 | Astrocytoma (HP:0009592) | 2.65643508 |
72 | Sensory axonal neuropathy (HP:0003390) | 2.65581904 |
73 | Nasolacrimal duct obstruction (HP:0000579) | 2.64866190 |
74 | Increased intramyocellular lipid droplets (HP:0012240) | 2.61560259 |
75 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.58818062 |
76 | Abnormality of the fovea (HP:0000493) | 2.57695441 |
77 | Increased serum pyruvate (HP:0003542) | 2.54902544 |
78 | Abnormality of glycolysis (HP:0004366) | 2.54902544 |
79 | Medial flaring of the eyebrow (HP:0010747) | 2.53367301 |
80 | Reduced antithrombin III activity (HP:0001976) | 2.52164809 |
81 | Increased connective tissue (HP:0009025) | 2.52118682 |
82 | Exertional dyspnea (HP:0002875) | 2.52039420 |
83 | Progressive external ophthalmoplegia (HP:0000590) | 2.51663379 |
84 | Short humerus (HP:0005792) | 2.50963134 |
85 | Preauricular skin tag (HP:0000384) | 2.48664816 |
86 | Microvesicular hepatic steatosis (HP:0001414) | 2.48053593 |
87 | Impulsivity (HP:0100710) | 2.47869777 |
88 | Abnormality of serum amino acid levels (HP:0003112) | 2.47294707 |
89 | Generalized hypotonia (HP:0001290) | 2.44828504 |
90 | Cerebral edema (HP:0002181) | 2.43236798 |
91 | Lactic acidosis (HP:0003128) | 2.43137582 |
92 | Congenital, generalized hypertrichosis (HP:0004540) | 2.43120418 |
93 | Abnormality of glycine metabolism (HP:0010895) | 2.42292248 |
94 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.42292248 |
95 | Nephronophthisis (HP:0000090) | 2.42156365 |
96 | Colon cancer (HP:0003003) | 2.39790856 |
97 | Abnormality of chromosome segregation (HP:0002916) | 2.39295876 |
98 | Congenital stationary night blindness (HP:0007642) | 2.38693508 |
99 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.37584192 |
100 | Hypochromic anemia (HP:0001931) | 2.36587461 |
101 | CNS demyelination (HP:0007305) | 2.35861256 |
102 | Premature ovarian failure (HP:0008209) | 2.35343584 |
103 | Dyskinesia (HP:0100660) | 2.34673144 |
104 | Villous atrophy (HP:0011473) | 2.30683328 |
105 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.30683328 |
106 | Sclerocornea (HP:0000647) | 2.30374699 |
107 | Shawl scrotum (HP:0000049) | 2.28284481 |
108 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.26725181 |
109 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.25747923 |
110 | Increased muscle lipid content (HP:0009058) | 2.25255051 |
111 | Tongue fasciculations (HP:0001308) | 2.25187138 |
112 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.23002828 |
113 | Malnutrition (HP:0004395) | 2.22727504 |
114 | Optic disc pallor (HP:0000543) | 2.22691443 |
115 | Hyperglycinuria (HP:0003108) | 2.22529033 |
116 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.20437167 |
117 | Large earlobe (HP:0009748) | 2.20215108 |
118 | Stenosis of the external auditory canal (HP:0000402) | 2.19952423 |
119 | Skin pits (HP:0100276) | 2.19856015 |
120 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.19139569 |
121 | Abnormality of urine glucose concentration (HP:0011016) | 2.19041198 |
122 | Glycosuria (HP:0003076) | 2.19041198 |
123 | Abnormality of vitamin B metabolism (HP:0004340) | 2.19008933 |
124 | Neurodegeneration (HP:0002180) | 2.18897005 |
125 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.18892679 |
126 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.18834455 |
127 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.18834455 |
128 | Microretrognathia (HP:0000308) | 2.17309115 |
129 | Hypobetalipoproteinemia (HP:0003563) | 2.16008760 |
130 | Abolished electroretinogram (ERG) (HP:0000550) | 2.14728236 |
131 | Muscle fibrillation (HP:0010546) | 2.13817695 |
132 | Supernumerary spleens (HP:0009799) | 2.13422596 |
133 | Ventricular tachycardia (HP:0004756) | 2.13396347 |
134 | Skin tags (HP:0010609) | 2.12217813 |
135 | Respiratory failure (HP:0002878) | 2.11987865 |
136 | Concave nail (HP:0001598) | 2.10119071 |
137 | Abnormality of the pubic bones (HP:0003172) | 2.08415055 |
138 | Septo-optic dysplasia (HP:0100842) | 2.08094452 |
139 | Respiratory difficulties (HP:0002880) | 2.07719403 |
140 | Cheilitis (HP:0100825) | 2.07119568 |
141 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.07029795 |
142 | Abnormality of renal resorption (HP:0011038) | 2.06372896 |
143 | Abnormality of the musculature of the hand (HP:0001421) | 2.05907617 |
144 | Lethargy (HP:0001254) | 2.05862715 |
145 | Delayed CNS myelination (HP:0002188) | 2.05182635 |
146 | Upper limb muscle weakness (HP:0003484) | 2.04604966 |
147 | Neoplasm of the heart (HP:0100544) | 2.04078402 |
148 | Exercise-induced muscle cramps (HP:0003710) | 2.04035777 |
149 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.03048118 |
150 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.03020266 |
151 | Congenital primary aphakia (HP:0007707) | 2.02789397 |
152 | Pseudobulbar signs (HP:0002200) | 2.02098137 |
153 | Abnormality of the labia minora (HP:0012880) | 1.99630915 |
154 | Gait imbalance (HP:0002141) | 1.99404193 |
155 | Abnormality of the lacrimal duct (HP:0011481) | 1.97650180 |
156 | Abnormal biliary tract physiology (HP:0012439) | 1.97328637 |
157 | Bile duct proliferation (HP:0001408) | 1.97328637 |
158 | Meckel diverticulum (HP:0002245) | 1.96968227 |
159 | Brushfield spots (HP:0001088) | 1.96844225 |
160 | Glossoptosis (HP:0000162) | 1.96708138 |
161 | Fasciculations (HP:0002380) | 1.93979110 |
162 | Exercise intolerance (HP:0003546) | 1.93781691 |
163 | Duplication of thumb phalanx (HP:0009942) | 1.93764427 |
164 | Hypopigmentation of the fundus (HP:0007894) | 1.93140657 |
165 | Abnormality of the renal medulla (HP:0100957) | 1.92782376 |
166 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.92486876 |
167 | Chronic hepatic failure (HP:0100626) | 1.91794958 |
168 | Glioma (HP:0009733) | 1.90306771 |
169 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.89651313 |
170 | Hypoplastic scapulae (HP:0000882) | 1.89651313 |
171 | Hemiparesis (HP:0001269) | 1.89565737 |
172 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.89535587 |
173 | Tubulointerstitial nephritis (HP:0001970) | 1.89427755 |
174 | Macrocytic anemia (HP:0001972) | 1.87518944 |
175 | Ketoacidosis (HP:0001993) | 1.86504962 |
176 | Carpal bone hypoplasia (HP:0001498) | 1.86065054 |
177 | Dicarboxylic aciduria (HP:0003215) | 1.85455624 |
178 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.85455624 |
179 | Type II lissencephaly (HP:0007260) | 1.85443967 |
180 | Nephrogenic diabetes insipidus (HP:0009806) | 1.84794076 |
181 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.84771753 |
182 | Patent foramen ovale (HP:0001655) | 1.83970357 |
183 | Abnormality of methionine metabolism (HP:0010901) | 1.83190153 |
184 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.82352261 |
185 | Generalized aminoaciduria (HP:0002909) | 1.81739196 |
186 | Renal cortical cysts (HP:0000803) | 1.79890032 |
187 | Poor head control (HP:0002421) | 1.77436682 |
188 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.76299755 |
189 | Abnormality of the renal cortex (HP:0011035) | 1.76267012 |
190 | Leukodystrophy (HP:0002415) | 1.75794520 |
191 | Cystic liver disease (HP:0006706) | 1.70846757 |
192 | Type I transferrin isoform profile (HP:0003642) | 1.70616244 |
193 | Poor suck (HP:0002033) | 1.70354175 |
194 | Attenuation of retinal blood vessels (HP:0007843) | 1.69363338 |
195 | Decreased muscle mass (HP:0003199) | 1.67128292 |
196 | Genital tract atresia (HP:0001827) | 1.65095999 |
197 | Abnormal glycosylation (HP:0012345) | 1.62475605 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 8.24548550 |
2 | GRK5 | 5.68572500 |
3 | GRK6 | 4.40654832 |
4 | ERN1 | 4.03560994 |
5 | GRK1 | 3.39540424 |
6 | ADRBK2 | 3.34245283 |
7 | FRK | 3.14780459 |
8 | MAP4K2 | 3.05581042 |
9 | VRK2 | 2.91172305 |
10 | GRK7 | 2.90056092 |
11 | ZAK | 2.86998877 |
12 | TTK | 2.81157281 |
13 | STK16 | 2.71915855 |
14 | CSF1R | 2.69615455 |
15 | MAPK7 | 2.55635474 |
16 | TGFBR2 | 2.54582203 |
17 | NUAK1 | 2.53142115 |
18 | TYRO3 | 2.49969809 |
19 | BMPR1B | 2.47986583 |
20 | WNK3 | 2.44160539 |
21 | MOS | 2.39843421 |
22 | INSRR | 2.29012229 |
23 | TLK1 | 2.15647413 |
24 | WNK1 | 2.14590840 |
25 | MATK | 2.09657801 |
26 | STK10 | 2.06701310 |
27 | VRK1 | 2.05044218 |
28 | EIF2AK3 | 2.03811744 |
29 | MST4 | 1.91644948 |
30 | PINK1 | 1.90180487 |
31 | CAMK4 | 1.49553650 |
32 | TXK | 1.47738399 |
33 | PRKG2 | 1.44339146 |
34 | NTRK1 | 1.43906200 |
35 | CASK | 1.43744055 |
36 | CDK7 | 1.43019063 |
37 | PLK3 | 1.38846295 |
38 | MAP2K4 | 1.38625251 |
39 | ACVR1B | 1.38003937 |
40 | MARK2 | 1.37868062 |
41 | TRIM28 | 1.34404548 |
42 | TGFBR1 | 1.34402877 |
43 | BRSK2 | 1.34175898 |
44 | TNIK | 1.33031064 |
45 | MKNK2 | 1.31361979 |
46 | ADRBK1 | 1.29606055 |
47 | TAF1 | 1.27719272 |
48 | TSSK6 | 1.25050554 |
49 | EPHA2 | 1.21341716 |
50 | MAP3K4 | 1.19237565 |
51 | SRPK1 | 1.17682726 |
52 | CHEK2 | 1.14368314 |
53 | MAPK12 | 1.09307791 |
54 | MAP2K6 | 1.08173144 |
55 | PLK1 | 1.07777983 |
56 | MKNK1 | 1.06841986 |
57 | PBK | 1.06240851 |
58 | HIPK2 | 1.05677779 |
59 | CSNK1G1 | 1.00621744 |
60 | MAPKAPK3 | 1.00522025 |
61 | PLK4 | 0.98908630 |
62 | OXSR1 | 0.98770012 |
63 | AKT3 | 0.97889907 |
64 | PASK | 0.96480062 |
65 | CSNK1G3 | 0.95755924 |
66 | CSNK1G2 | 0.94058649 |
67 | WNK4 | 0.92664945 |
68 | MAP3K7 | 0.90473806 |
69 | MAPKAPK5 | 0.90238077 |
70 | STK39 | 0.89046512 |
71 | MAPK13 | 0.87717469 |
72 | AKT2 | 0.87327117 |
73 | MAP2K7 | 0.83736845 |
74 | PAK4 | 0.83028567 |
75 | ERBB3 | 0.82521567 |
76 | PDK3 | 0.78121356 |
77 | PDK4 | 0.78121356 |
78 | TIE1 | 0.76790285 |
79 | PKN1 | 0.74904820 |
80 | FGFR3 | 0.74123257 |
81 | PLK2 | 0.71533589 |
82 | MUSK | 0.70748394 |
83 | PRKCE | 0.69979104 |
84 | CSNK1A1L | 0.67076895 |
85 | RPS6KA5 | 0.66267152 |
86 | DYRK3 | 0.66046956 |
87 | BUB1 | 0.65896716 |
88 | MAP3K10 | 0.65774257 |
89 | CHEK1 | 0.64929360 |
90 | LATS2 | 0.63978138 |
91 | STK3 | 0.63363267 |
92 | PNCK | 0.63226364 |
93 | STK38L | 0.62845349 |
94 | TAOK3 | 0.61367579 |
95 | ATR | 0.60471632 |
96 | NME2 | 0.57663336 |
97 | MAP3K9 | 0.56147058 |
98 | ABL2 | 0.55573720 |
99 | AURKA | 0.54617010 |
100 | PIM1 | 0.51657829 |
101 | FGFR2 | 0.50514657 |
102 | BCKDK | 0.48289561 |
103 | CAMK2A | 0.48204403 |
104 | PRKCQ | 0.47536529 |
105 | CSNK2A1 | 0.47329811 |
106 | RPS6KB2 | 0.47142140 |
107 | EIF2AK1 | 0.47094072 |
108 | ALK | 0.44651531 |
109 | NEK2 | 0.44633405 |
110 | LMTK2 | 0.43941380 |
111 | NME1 | 0.43215899 |
112 | CSK | 0.42049902 |
113 | EIF2AK2 | 0.41752549 |
114 | TEC | 0.41488011 |
115 | CSNK1A1 | 0.40464266 |
116 | CSNK2A2 | 0.40399985 |
117 | MTOR | 0.40303460 |
118 | PRKCI | 0.39016341 |
119 | BCR | 0.38911946 |
120 | IGF1R | 0.38599934 |
121 | STK24 | 0.38045451 |
122 | TAOK2 | 0.37919556 |
123 | CDK2 | 0.35663086 |
124 | MAPK15 | 0.35488224 |
125 | MARK3 | 0.35161013 |
126 | WEE1 | 0.35151813 |
127 | LIMK1 | 0.35143058 |
128 | PIM2 | 0.34722024 |
129 | PDK2 | 0.34231721 |
130 | CSNK1E | 0.34229061 |
131 | CDK4 | 0.34136700 |
132 | NEK1 | 0.33064378 |
133 | CCNB1 | 0.33056992 |
134 | AURKB | 0.30095128 |
135 | MAPK10 | 0.29843541 |
136 | PRKCD | 0.28612510 |
137 | CDC7 | 0.28135507 |
138 | MAPK4 | 0.27925910 |
139 | PRKD2 | 0.27109034 |
140 | ITK | 0.25090851 |
141 | PRKCG | 0.24599975 |
142 | TNK2 | 0.23368854 |
143 | PRKACA | 0.23074483 |
144 | PAK1 | 0.23020930 |
145 | DYRK1A | 0.21460487 |
146 | ATM | 0.21323184 |
147 | TAOK1 | 0.20794321 |
148 | PRKACG | 0.20508438 |
149 | PRKAA1 | 0.19358407 |
150 | CDK1 | 0.19348138 |
151 | PRKACB | 0.18581833 |
152 | ERBB2 | 0.18525264 |
153 | EPHA4 | 0.17053268 |
154 | GSK3B | 0.16167936 |
155 | OBSCN | 0.15801753 |
156 | PHKG2 | 0.15257648 |
157 | PHKG1 | 0.15257648 |
158 | DYRK2 | 0.15050135 |
159 | PAK3 | 0.13436616 |
160 | STK38 | 0.12268345 |
161 | CDK19 | 0.12099832 |
162 | CDK15 | 0.11787511 |
163 | INSR | 0.11704911 |
164 | MAPK14 | 0.10828345 |
165 | CDK11A | 0.10685282 |
166 | MAPK1 | 0.10554140 |
167 | PTK2 | 0.10548990 |
168 | IKBKB | 0.10003156 |
169 | RPS6KA3 | 0.09353676 |
170 | PRKAA2 | 0.08632578 |
171 | CDK18 | 0.07854585 |
172 | TTN | 0.07819229 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 7.04549339 |
2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.76221046 |
3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.05216955 |
4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.66797006 |
5 | Proteasome_Homo sapiens_hsa03050 | 3.13370414 |
6 | Protein export_Homo sapiens_hsa03060 | 2.82836213 |
7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.79562913 |
8 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.57063197 |
9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.53958361 |
10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.34246163 |
11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.20536932 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10372490 |
13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.00300157 |
14 | Ribosome_Homo sapiens_hsa03010 | 1.90642095 |
15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84084304 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83768792 |
17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.83411391 |
18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82709554 |
19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68687315 |
20 | Phototransduction_Homo sapiens_hsa04744 | 1.50055002 |
21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41914008 |
22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40918738 |
23 | RNA transport_Homo sapiens_hsa03013 | 1.39548149 |
24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.36926107 |
25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.36209308 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36178271 |
27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29782397 |
28 | RNA polymerase_Homo sapiens_hsa03020 | 1.27520846 |
29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23488270 |
30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22975477 |
31 | Thyroid cancer_Homo sapiens_hsa05216 | 1.22325922 |
32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20771067 |
33 | Purine metabolism_Homo sapiens_hsa00230 | 1.18069172 |
34 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.11914979 |
35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.11691058 |
36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.10478746 |
37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08885419 |
38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03678208 |
39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01558758 |
40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00835500 |
41 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00777138 |
42 | Base excision repair_Homo sapiens_hsa03410 | 0.99955876 |
43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.98629871 |
44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96320088 |
45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96239454 |
46 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.95751482 |
47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95563918 |
48 | RNA degradation_Homo sapiens_hsa03018 | 0.95438338 |
49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95050357 |
50 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.93962380 |
51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92336845 |
52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91786021 |
53 | Homologous recombination_Homo sapiens_hsa03440 | 0.91722756 |
54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91554506 |
55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90644899 |
56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89858638 |
57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89799155 |
58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87574614 |
59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86909707 |
60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82892334 |
61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.82484119 |
62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81205971 |
63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80851519 |
64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80241983 |
65 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.79942032 |
66 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79770736 |
67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79138998 |
68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.78949916 |
69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78417943 |
70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76298443 |
71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75623526 |
72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74914005 |
73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72221365 |
74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70894630 |
75 | Nicotine addiction_Homo sapiens_hsa05033 | 0.69939707 |
76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67934999 |
77 | Cell cycle_Homo sapiens_hsa04110 | 0.66794882 |
78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66486353 |
79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65630906 |
80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65456854 |
81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63500681 |
82 | Asthma_Homo sapiens_hsa05310 | 0.63163596 |
83 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63036991 |
84 | DNA replication_Homo sapiens_hsa03030 | 0.62307276 |
85 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61921944 |
86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60565114 |
87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60560365 |
88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59729232 |
89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56590097 |
90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55843063 |
91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55515913 |
92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55335200 |
93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52221973 |
94 | Mismatch repair_Homo sapiens_hsa03430 | 0.52056404 |
95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51573833 |
96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50629083 |
97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50317884 |
98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49552487 |
99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49363978 |
100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49263876 |
101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48132548 |
102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47930952 |
103 | Allograft rejection_Homo sapiens_hsa05330 | 0.47325331 |
104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47060721 |
105 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46718326 |
106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46317459 |
107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45489391 |
108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45382536 |
109 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45329712 |
110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45042248 |
111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44935749 |
112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44727551 |
113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43018896 |
114 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41870005 |
115 | Spliceosome_Homo sapiens_hsa03040 | 0.41264982 |
116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39914509 |
117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39657177 |
118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39631996 |
119 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.39604172 |
120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39462848 |
121 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.38988546 |
122 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38595066 |
123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.36785153 |
124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36430469 |
125 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35174997 |
126 | Taste transduction_Homo sapiens_hsa04742 | 0.34845440 |
127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34483467 |
128 | Pathways in cancer_Homo sapiens_hsa05200 | 0.33973200 |
129 | Peroxisome_Homo sapiens_hsa04146 | 0.33847255 |
130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33350422 |
131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32503182 |
132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32418061 |
133 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.32120464 |
134 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30371420 |
135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30184823 |
136 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.30113389 |
137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28803385 |
138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28317773 |
139 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.26258142 |
140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25910445 |
141 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.25751316 |
142 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24528008 |
143 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23767784 |
144 | Morphine addiction_Homo sapiens_hsa05032 | 0.23584903 |
145 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.22524229 |